Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Cancer Research

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-0860PMID 17085646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen Receptor-Positive, Progesterone Receptor-Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

  2006cited by this paper
• Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

  2005cited by this paper
• GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release.

  2005cited by this paper
• Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer.

  2005cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

  2005cited by this paper
• 14-3-3σ Expression Is an Independent Prognostic Parameter for Poor Survival in Colorectal Carcinoma Patients

  2005cited by this paper
• New developments in the treatment of postmenopausal breast cancer.

  2005cited by this paper
• Evolving understanding of growth regulation in human breast cancer: interactions of the steroid and peptide growth regulatory pathways.

  2005cited by this paper
• Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.

  2005cited by this paper
• A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

  2005cited by this paper
• Immunohistochemical visualization of corticotropin‐releasing factor type 1 (CRF1) receptors in monkey brain

  2004cited by this paper
• Estrogen receptor knockout mice: phenotypes in the female reproductive tract

  2003cited by this paper
• Accumulation of uPA – PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer

  2003cited by this paper
• Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

  2003cited by this paper
• Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.

  2002cited by this paper
• The pure anti‐oestrogen ICI 182,780 (Faslodex™) activates large conductance Ca2+‐activated K+ channels in smooth muscle

  2002cited by this paper
• Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.

  2002cited by this paper
• Prognostic factors in breast cancer

  2002cited by this paper
• T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases

  2002cited by this paper
• Estrogen Action Via the G Protein-Coupled Receptor , GPR 30 : Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis

  2001cited by this paper
• Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.

  2001cited by this paper
• Predicting Axillary Nodal Positivity in 2282 Patients with Breast Carcinoma

  2001cited by this paper
• C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.

  2001cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Role for Akt in Mediating the Estrogenic Functions of Epidermal Growth Factor and Insulin-Like Growth Factor I*

  2000cited by this paper
• Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer.

  2000cited by this paper
• Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

  2000cited by this paper
• Modulation of the intracellular calcium level in mammalian cells caused by 17beta-estradiol, different phytoestrogens and the anti-estrogen ICI 182780.

  1999cited by this paper
• Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat

  1999cited by this paper
• Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential.

  1998cited by this paper
• Predictors of Axillary Lymph Node Metastases in Patients with T1 Breast Carcinoma

  1998cited by this paper
• Phospholipase C β and Membrane Action of Calcitriol and Estradiol*

  1997cited by this paper
• Predictors of axillary lymph node metastases in patients with T1 breast carcinoma

  1997cited by this paper
• 17 beta-estradiol stimulates a rapid Ca2+ influx in LNCaP human prostate cancer cells.

  1996cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• 17β-Estradiolid Ca influx rapid Ca2+ prostate cancer cells

  1996cited by this paper
• ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors

  1995cited by this paper
• Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding.

  1995cited by this paper
• Prognosis of breast cancer: Evidence for interaction between c‐erbB‐2 overexpression and number of involved axillary lymph nodes

  1995cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper
• Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.

  1994cited by this paper
• Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators.

  1994cited by this paper
• Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets

  1994cited by this paper
• A new, nongenomic estrogen action: the rapid release of intracellular calcium.

  1992cited by this paper
• Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation.

  1991cited by this paper
• Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid.

  1988cited by this paper
• Regulation of epidermal growth factor receptor by estrogen.

  1985cited by this paper

• Metamifop-induced human breast cancer cells proliferation: Revealing a proliferation mechanism distinct from 17β-estradiol

  2026cites this paper
• Endocrine therapy resistance of breast cancer: Important role of G protein-coupled estrogen receptor (GPER) and new therapeutic strategies

  2025cites this paper
• Research Progress of Docetaxel Nano-Drug Delivery System in the Treatment of Breast Cancer

  2025cites this paper
• G protein-coupled estrogen receptor biased signaling in health and disease.

  2025cites this paper
• Production of recombinant human G protein-coupled estrogen receptor (GPER) and establishment of a ligand binding assay using graphene quantum dots (GQDs)

  2025cites this paper
• Aryl hydrocarbon receptor-ligand hexachlorobenzene promotes immunosuppression leading to mammary tumor growth and metastasis in a HER2-positive syngeneic mouse model.

  2025cites this paper
• Endocrine-disrupting chemicals as prostate carcinogens

  2025cites this paper
• Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?

  2025cites this paper
• Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer

  2025cites this paper
• Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor

  2024cites this paper
• G protein-coupled receptor-targeted proteolysis-targeting chimeras in cancer therapeutics.

  2024cites this paper
• Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer

  2024cites this paper
• Establishing and Validating an Innovative Focal Adhesion-Linked Gene Signature for Enhanced Prognostic Assessment in Endometrial Cancer

  2024cites this paper
• Advances in immune regulation of the G protein-coupled estrogen receptor.

  2024cites this paper
• Atrazine promotes cholangiocarcinoma cell proliferation and migration via GPER-mediated PI3K/Akt/NF-κB pathway.

  2024cites this paper
• G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells

  2024cites this paper
• The G Protein-Coupled Estrogen Receptor GPER in the Development and Progression of Cancer

  2024cites this paper
• The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer

  2024cites this paper
• G protein-coupled estrogen receptor 1 and collagen XVII endodomain expression in human cutaneous melanomas: can they serve as prognostic factors?

  2024cites this paper
• GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma

  2023cites this paper
• GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway

  2023cites this paper
• The G protein-coupled oestrogen receptor GPER in health and disease: an update

  2023cites this paper
• Different Expression Pattern of G Protein-Coupled Estrogen Receptor GPER1 in Esophageal Squamous Cell Carcinoma and Adenocarcinoma

  2023cites this paper
• Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer

  2023cites this paper
• Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives

  2023cites this paper
• G protein-coupled estrogen receptor in GtoPdb v.2023.1

  2023cites this paper
• G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications

  2023cites this paper
• Breast cancer progression and kynurenine pathway enzymes are induced by hexachlorobenzene exposure in a Her2-positive model.

  2023cites this paper
• An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management

  2023cites this paper
• Oestrogen receptor-independent actions of oestrogen in cancer

  2023cites this paper
• The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer

  2023influential citation
• The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.

  2023cites this paper
• Comparison of transcriptome alterations induced by pendimethalin or its commercial formulation Stomp Aqua in human MCF-7, MCF-10 A and MCF-12 A mammary epithelial cells

  2023cites this paper
• Transcriptome analysis of human mammary epithelial cells treated with bisphenol A and bisphenol A analogue mixtures reveals major alterations in multiple cellular pathways

  2022cites this paper
• The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells

  2022cites this paper
• Expression of G-Protein-Coupled Estrogen Receptor (GPER) in Whole Testicular Tissue and Laser-Capture Microdissected Testicular Compartments of Men with Normal and Aberrant Spermatogenesis

  2022cites this paper
• Upregulation of CYP1B1 by hypoxia is mediated by ERα activation in breast cancer cells.

  2022cites this paper
• Intercommunication between Voltage-Gated Calcium Channels and Estrogen Receptor/Estrogen Signaling: Insights into Physiological and Pathological Conditions

  2022cites this paper
• Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: In vivo, in vitro and in silico studies.

  2022cites this paper
• GPER limits adverse changes to Ca2+ signalling and arrhythmogenic activity in ovariectomised guinea pig cardiomyocytes

  2022cites this paper
• GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells

  2022cites this paper
• Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse

  2022cites this paper
• Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape

  2022cites this paper
• Rewiring of the Endocrine Network in Triple-Negative Breast Cancer

  2022cites this paper
• High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes

  2022cites this paper
• Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody

  2022cites this paper
• The G-Protein–Coupled Estrogen Receptor Agonist G-1 Inhibits Proliferation and Causes Apoptosis in Leukemia Cell Lines of T Lineage

  2022cites this paper
• Localisation of oestrogen receptors in stem cells and in stem cell‐derived neurons of the mouse

  2022cites this paper
• The Interplay of GPER1 with 17β-Aminoestrogens in the Regulation of the Proliferation of Cervical and Breast Cancer Cells: A Pharmacological Approach

  2022cites this paper
• Breast Cancer Biomarkers with Clinical Relevance Identified by Massively-parallel DNA and RNA Sequencing

  2021cites this paper
• An Insight into GPCR and G-Proteins as Cancer Drivers

  2021cites this paper
• The impact of G protein-coupled oestrogen receptor 1 on male breast cancer: a retrospective analysis

  2021cites this paper
• Hormonal Carcinogenesis in Canine Mammary Cancer: Molecular Mechanisms of Estradiol Involved in Malignant Progression

  2021cites this paper
• Binding of Androgen- and Estrogen-Like Flavonoids to Their Cognate (Non)Nuclear Receptors: A Comparison by Computational Prediction

  2021cites this paper
• GPER and Testicular Germ Cell Cancer

  2021cites this paper
• Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors.

  2021cites this paper
• G Protein-Coupled Estrogen Receptor in Cancer and Stromal Cells: Functions and Novel Therapeutic Perspectives

  2021cites this paper
• G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models

  2021cites this paper
• The gene expression of GPER1 is low in fresh samples of papillary thyroid carcinoma (PTC), and in silico analysis.

  2021cites this paper
• GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells

  2021cites this paper
• Environmental Estrogens and Their Biological Effects through GPER Mediated Signal Pathways.

  2021cites this paper
• Relationship between the G protein–coupled oestrogen receptor and spermatogenesis, and its correlation with male infertility

  2020cites this paper
• Computational Approaches for the Discovery of GPER Targeting Compounds

  2020cites this paper
• Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease

  2020cites this paper
• GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)

  2020cites this paper
• GPER1, estrogen receptors and androgen receptor in the sand rat (Psammomys obesus) efferent ducts.

  2020cites this paper
• Canine mammary cancer

  2020cites this paper
• Role of aromatase activation on sodium arsenite-induced proliferation, migration, and invasion of MDA-MB-231 and MDA-MB-453 breast cancer cell lines.

  2020cites this paper
• Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer

  2020cites this paper
• Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers

  2020cites this paper
• G protein coupled oestrogen receptor 1, aromatase, 17β-HSD and cAMP level in mutational falsetto

  2020cites this paper
• The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis.

  2020cites this paper
• GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells.

  2020cites this paper
• G protein-coupled oestrogen receptor 1, oestrogen receptors and androgen receptor in the sand rat (Psammomys obesus) efferent ducts

  2020cites this paper
• Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function

  2020cites this paper
• Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells

  2020cites this paper
• Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation

  2020cites this paper
• The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.

  2020cites this paper
• Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.

  2020cites this paper
• Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling

  2020cites this paper
• The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis

  2020influential citation
• 17β‐Estradiol via Orai1 activates calcium mobilization to induce cell proliferation in epithelial ovarian cancer

  2020cites this paper
• GPER1 and microRNA: Two Players in Breast Cancer Progression

  2020cites this paper
• Bisphenol A promotes the proliferation of leiomyoma cells by GPR30‐EGFR signaling pathway

  2019cites this paper
• pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments

  2019cites this paper
• Plasma membrane G protein-coupled estrogen receptor 1 (GPER) mediates rapid estradiol facilitation of sexual receptivity through the orphanin-FQ-ORL-1 system in estradiol primed female rats.

  2019cites this paper
• Structure, Function, and Relationship of Estrogens

  2019cites this paper
• Environmental pollutants-dependent molecular pathways and carcinogenesis

  2019cites this paper
• Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF.

  2019cites this paper
• Is testicular germ cell cancer (TGCC) estrogen dependent? The role of endocrine disrupting chemicals (EDCs).

  2019cites this paper
• Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure

  2019cites this paper
• The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast

  2019cites this paper
• G-Protein Coupled Estrogen Receptor in Breast Cancer

  2019cites this paper
• Tissue Distribution and Systemic Toxicity Evaluation of Raloxifene Targeted Polymeric Micelles of Poly (Styrene-Maleic Acid)-Poly (Amide-Ether-Ester-Imide)-Poly (Ethylene Glycol) Loaded With Docetaxel in Breast Cancer Bearing Mice.

  2019cites this paper
• G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells

  2019cites this paper
• Molecular mechanism of endocrine-disruptive effects induced by Bisphenol A: The role of transmembrane G-protein estrogen receptor 1 and integrin αvβ3.

  2019cites this paper
• Exposure to bisphenol A: current levels from food intake are toxic to human cells

  2019cites this paper
• G protein-coupled estrogen receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells

  2019cites this paper
• Aldosterone rapidly activates p-PKC delta and GPR30 but suppresses p-PKC epsilon protein levels in rat kidney

  2019cites this paper